A fitted number needs a revealing experiment.
A kinetic-data specification for deciding whether the observed substrate and time ranges can distinguish the parameters an assay team wants to use.
Proposed evidence-engineering direction | External sources and defined methods; scope, rights and delivery capacity to be agreed.
The desired parameter should shape the experiment
Choose the kinetic quantity that matters to the assay decision, then check whether the observed range contains information about it.
A kinetic fit can return a number even when the experiment contains little information about it. The proposed analysis starts by asking which parameter would change the assay decision and which measured conditions could reveal it. A substrate range concentrated in one limiting regime may identify a ratio more readily than its separate components. A time course may also depend on enzyme activity loss or substrate depletion. The buyer needs to know whether the proposed experiment can discriminate those explanations, rather than assuming that an optimiser’s successful completion makes every fitted parameter useful for choosing an assay or material architecture.
Examine the development decision
A fitted number needs a revealing experiment.
Open the sequence to examine what a development decision needs.
Identify the exact preparation, its source, and the properties a second laboratory must be able to reproduce.
Explanatory geometry · no simulated or measured performance
Defining the measured rate and concentration
Keep rate definitions, concentration conventions and catalyst identity together when assessing whether reported kinetic parameters belong in one comparison.
STRENDA asks for the kinetic equation, parameter units and method used to obtain them, together with assay conditions and catalyst identity (STRENDA Commission, 2021). The proposed record would retain those fields before fitting. It would identify whether the response is an initial rate, integrated optical signal or a fitted progress-curve quantity. It would also preserve the measured substrate and catalyst concentration basis. An optical signal may need a calibrated relation to reaction progress; otherwise its units and scaling remain instrument-specific. This makes a later parameter comparison inspectable and prevents an arbitrary detector response from being treated as an absolute catalytic rate.
The limiting regime exposes a different quantity
Inspect the low-substrate regime to see which parameter combination the observations constrain and which separate quantities may remain unresolved.
For a defined Michaelis–Menten rate model, the low-substrate regime approaches a slope involving Vmax divided by Km. That mathematical limit explains why measuring only low concentrations may leave the separate parameters poorly resolved. It is not an assertion that every luciferase follows that model or that Km is binding affinity. Nemergut et al. (2023) illustrate the importance of a source-defined kinetic model and substrate context. The proposed comparison would retain the original model and observed range, then ask which additional concentration points or controls would improve discrimination rather than fitting a familiar equation merely because its parameters are recognisable.
The low-substrate slope does not separately identify Vmax and Km.
- Rate under the stated modelConcentration time⁻¹
- Maximum rate parameterConcentration time⁻¹
- Defined substrate concentrationConcentration
- Model half-rate concentration parameterConcentration
Model conditions. Appropriate Michaelis–Menten model Initial-rate conditions and low-substrate approximation No binding-affinity interpretation or fit asserted
Keep the conditions attached to the result.
Make scientific records useful through source-linked comparisons, explicit units and a reproducible decision trail.
Progress curves can contain competing mechanisms
Compare substrate depletion, inactivation and measurement limitations before assigning a changing progress curve to one preferred biochemical mechanism.
A decreasing optical response might reflect a changing substrate concentration, enzyme inactivation, mixing delay or a detector limitation. The proposed kinetic record would include controls capable of separating those possibilities and would preserve the time origin and instrument window. A model fitted to the same curve cannot establish a mechanism simply because it reproduces the shape. Where several models give similar predictions in the measured range, a targeted perturbation may be more informative than another optimiser. The buyer’s decision is then about which experiment can separate explanations, with each candidate model’s assumptions stated before new measurements are commissioned.
The detail of residuals and parameter sensitivity together
Examine residual patterns and parameter sensitivity together so that a flattering fit statistic cannot conceal a weakly identified quantity.
NIST’s modelling guidance explains why a high R² alone is insufficient for judging a fit (NIST/SEMATECH, n.d.). For kinetic work, the proposed review would combine residual inspection with parameter sensitivity, boundary checks and alternative initialisation. A parameter that changes greatly while predicted curves remain similar deserves careful interpretation. The report would distinguish numerical convergence from practical identifiability and would not turn a narrow optimiser error estimate into a guarantee of experimental precision. A partner could use that diagnosis to refine the concentration range, improve calibration or narrow the parameter claim to the quantity the observations actually resolve.
Retain the published and reproduced layers
Compare published parameters with separately reproduced arithmetic, preserving source discrepancies rather than forcing every reported value into agreement.
The existing NanoLuc analysis keeps reported parameters separate from arithmetic reproduced from reported means. That distinction matters when a source contains an unresolved numerical inconsistency. The proposed service would record the original table location, model, units and any reproduction without silently replacing the publication. A fitted value from raw data would be another layer with its own objective and uncertainty basis. This gives an assay team a traceable route from source to comparison and helps an investor or application sponsor see which part of the proposed value is an external observation, a calculation or a hypothesis awaiting an experiment.
A practical assay-development deliverable
Specify the parameter, source domain and discriminating observations a prospective assay brief would need before another fitting exercise becomes useful.
The proposed brief would identify the decision-critical parameter, eligible source ranges, model alternatives and the concentration/time observations needed to distinguish them. It would specify controls, fit objectives and the acceptance task for a reproduced analysis. A partner could use it to plan a bounded assay comparison without committing immediately to a broad screening programme. Any new data collection or delivered modelling would need an agreed scope, instrument route and capacity. The commercial proposition is precision in deciding what to measure; it is not a claim that Bio has validated a kinetic assay or can guarantee a particular parameter estimate.
The next proposed comparison.
A parameter/observability map and a concentration–time comparison plan
Spend the next measurement where models disagree
Measure where plausible mechanisms predict different responses, turning model ambiguity into a concrete concentration or time-course experiment worth discussing.
When plausible models agree across the observed range, repeating the same conditions may add precision without answering the unresolved mechanism question. The next useful observation is often a condition at which those models predict materially different behaviour, provided the measurement remains feasible and interpretable. The proposed plan would state that discriminating condition and the finding that would change the model choice. It would also define when the remaining ambiguity is irrelevant to the application decision. This keeps parameter work connected to a development outcome and prevents an elegant fit from becoming an end in itself.
Evidence engineering · Proposed development discussion
A development path
for this research.
The kinetic parameters a proposed experiment can identify
The people this could serve.Formulation, application-science and research-data teams.
The decision behind the project.
Your intended application, present alternative and the constraint behind “Kinetic parameter identifiability”. A useful starting point is the change that would justify another development step.
A proposed scope centred on a parameter/observability map and a concentration–time comparison plan.
Agree the comparison, acceptance basis and responsible expertise before discussing a paid package.
Specialist methods and a defined contribution.
Bring relevant analytical or experimental expertise, a comparator suggestion, and the conditions under which your method could resolve this question.
A jointly scoped proposal could connect your contribution with a parameter/observability map and a concentration–time comparison plan.
Define contributions, required access, independent preparations and permitted outputs before work or protected information is shared.
The commercial purpose of the next milestone.
Bring the application or asset thesis, the buyer you expect to value it, and the scientific or commercial uncertainty that must be resolved before another commitment.
The proposed decision record would connect the buyer question with a parameter/observability map and a concentration–time comparison plan. It would identify what a subsequent comparison needs to demonstrate.
Demand, development cost, resources, rights and a decision-changing milestone would need examination. No financing terms or investment outcome are represented here.
What a useful comparison
would record.
- Record rate under the stated model (Concentration time⁻¹) with the preparation, method and conditions needed to interpret it.
- Record maximum rate parameter (Concentration time⁻¹) with the preparation, method and conditions needed to interpret it.
- Record defined substrate concentration (Concentration) with the preparation, method and conditions needed to interpret it.
What the proposed
brief could leave behind.
- A parameter/observability map and a concentration–time comparison plan
- A preparation, comparator and endpoint record tied to this question.
- A source-linked account of the evidence gaps, study assumptions and next review point.
The proposed discussion brief
A brief you
can take away.
Use non-confidential notes to connect this topic with your own decision. Entries stay in this browser tab; saving creates a text file on your device. Nothing is submitted.
A scoped evidence/data decision brief or qualified comparison programme; recurring or API access only after delivery capacity and repeat buyer value are established.
Notes are optional. The brief includes this page’s proposed question and public source links.
Proposed scope; resources, methods, rights and delivery terms would be agreed before work. Begin with non-confidential information.
Sources and reading notes.
External work is identified below. Access notes describe the material inspected for this page; company research questions and proposed work are not presented as findings from these sources.
STRENDA Commission, 2021STRENDA Commission (2021) Guidelines Lists Level 1A and 1B, version 1.8
Catalyst identity, assay conditions, activity units, replicate definitions and model reporting.
Scope and limitations: Reporting guidance, not assay approval or a probabilistic quality score.
Open original sourceNemergut et al., 2023Nemergut et al. (2023) Illuminating the mechanism and allosteric behavior of NanoLuc luciferase
Source kinetic table and full method context for within-study variants and substrates.
Scope and limitations: Efficiency is not brightness or affinity. Reported CTZ triple efficiency differs from quotient of reported means; no Bio result.
Open original sourceNIST/SEMATECH, n.d.NIST/SEMATECH (n.d.) e-Handbook: How can I tell if a model fits my data?
Residual definition and why R² alone cannot validate a model.
Scope and limitations: General modelling guidance, not a Bio model-validation result.
Open original source
Film credits

